A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines

Cellular Immunology

Volumn 259, Issue 1, 2009, Pages 90-99

  Assaf, Areej ^a   Esteves, Helia ^a   Curnow, S John ^b   Browning, Michael J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CpG ODN; NF B; Reverse transcriptase polymerase chain reaction; TLR9; Toll like receptor

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; BONE MARROW TUMOR; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; MYELOMA CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LYMPHOCYTE CULTURE TEST, MIXED; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; RNA, MESSENGER; TOLL-LIKE RECEPTOR 9; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 68549103458     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.06.003     Document Type: Article

References (35)

1. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
2. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S.A. Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
3. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., and Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194 (2001) 863-869
4. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A.M., and Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells, which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31 (2001) 3026-3037
5. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 (2002) 4531-4537
6. Dasari P., Nicholson I.C., Hodge G., Dandie G.W., and Zola H. Expression of toll-like receptors on B lymphocytes. Cell Immunol. 236 (2005) 140-145
7. Vollmer J. Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9. Expert Opin. Biol. Ther. 5 (2005) 673-682
8. Hayashi F., Means T.K., and Luster A.D. Toll-like receptors stimulate human neutrophil function. Blood 102 (2003) 2660-2669
9. Nagase H., Okugawa S., Ota Y., Yamaguchi M., Tomizawa H., Matsushima K., Ohta K., Yamamoto K., and Hirai K. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 171 (2003) 3977-3982
10. Roda J.M., Parihar R., and Carson III W.E. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J. Immunol. 175 (2005) 1619-1627
11. Akhtar M., Watson J.L., Nazli A., and McKay D.M. Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-kappaB-independent pathway. FASEB J. 17 (2003) 1319-1321
12. Platz J., Beisswenger C., and Dalpke A. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J. Immunol. 173 (2004) 1219-1223
13. Pedersen G., Andresen L., Matthiessen M.W., Rask-Madsen J., and Brynskov J. Expression of toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Clin. Exp. Immunol. 141 (2005) 298-306
14. Lebre M.C., van der Aar A.M., van Baarsen L., van Capel T.M., Schuitemaker J.H., Kapsenberg M.L., and de Jong E.C. Human keratinocytes express functional toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127 (2007) 331-341
15. Droemann D., Albrecht D., Gerdes J., Ulmer A.J., Branscheid D., Vollmer E., Dalhoff K., Zabel P., and Goldmann T. Human lung cancer cells express functionally active toll-like receptor 9. Respir. Res. 6 (2005) 1-10
16. Leifer C.A., Brooks J.C., Hoelzer K., Lopez J., Kennedy M.N., Mazzoni A., and Segal D.M. Cytoplasmic targeting motifs control localization of toll-like receptor 9. J. Biol. Chem. 281 (2006) 35585-35592
17. Kim Y.M., Brinkmann M.M., Paquet M.E., and Pleogh H.L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452 (2008) 234-238
18. Ewald S.E., Lee B.L., Lau L., Wickliffe K.E., Shi G.P., Chapman H.A., and Barton G.M. The ectodomain of toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456 (2008) 658-662
19. Leifer C.A., Kennedy M.N., Mazzoni A., Lee C., Kruhlak M.J., and Segal D.M. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173 (2004) 1179-1183
20. He B., Quao X., and Cerutti A. CpG ODN induces IgG class switch recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173 (2004) 4479-4491
21. Teobald I., Dunnion D.J., Whitbread M., Curnow S.J., and Browning M.J. Phenotypic and functional differentiation of KG-1 into dendritic-like cells. Immunobiology 213 (2008) 75-86
22. Jahrsdorfer B., Muhlenhoff L., Blackwell S.E., Wagner M., Poeck H., Hartmann E., Jox R., Giese T., Emmerich B., Endres S., Weiner G.J., and Hartmann G. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Clin. Cancer Res. 11 (2005) 1490-1499
23. Longo P.G., Laurenti L., Gobessi S., Petlickovski A., Pelosi M., Chiusolo P., Sica S., Leone G., and Efremov D.G. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia 21 (2007) 110-120
24. Gantner F., Hermann P., Nakashima K.M., Masukawa S., Sakai K., and Bacon K.B. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur. J. Immunol. 33 (2003) 1576-1585
25. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., and Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34 (2004) 251-262
26. Henault M., Lee L.N., Evans G.F., and Zuckerman S.H. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of toll-like receptor 9 and activation by CpG oligonucleotides. J. Immunol. Methods 300 (2005) 93-99
27. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., Nacken W., Foell D., van der Poll T., Sorg C., and Roth J. Mrp8 and Mrp14 are endogenous activators of toll-like receptor 4, promoting lethal endotoxin-induced shock. Nat. Med. 13 (2007) 1042-1049
28. Yamazoe M., Nishitani C., Takahashi M., Katoh T., Ariki S., Shimizu T., Mitsuzawa H., Sawada K., Voelker D.R., Takahashi H., and Kuroki Y. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J. Biol. Chem. 283 (2008) 35878-35888
29. Kawai T., and Akira S. Toll-like receptor and RIG-1-like receptor signalling. Ann. NY Acad. Sci. 1143 (2008) 1-20
30. Scheibenbogen C., Keilholz U., Meuer S., Dengler T., Tilgen W., and Hunstein W. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines. Int. J. Cancer 54 (1993) 494-498
31. Street D., Kaufman A.M., Vaughan A., Fisher S.G., Hunter M., Schreckenberger C., Potkul R.K., Gissmann L., and Qiao L. Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumour-specific cytotoxic T cells. Gynecol. Oncol. 65 (1997) 265-272
32. Farmer I., Freysdottir J., Dalghous A.M., and Fortune F. Expression of adhesion and activation molecules in human buccal epithelial cell lines and normal human buccal epithelium in situ. J. Oral Pathol. Med. 30 (2001) 113-120
33. Washburn B., and Schirrmacher V. Human tumor cell infection by newcastle disease virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis. Int. J. Oncol. 21 (2002) 85-93
34. Mulcahy K.A., Alexander S., Platts K.E., Wardle C., Sisley K., Rennie I.G., and Murray A.K. CD80-mediated induction of immunostimulation in two ocular melanoma cell lines is augmented by interferon-gamma. Melanoma Res. 12 (2002) 129-138
35. Shishodia S., Amin H.M., Lai R., and Aggarwal B.B. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol. 70 (2005) 700-713